MIF inhibition alleviates vitiligo progression by suppressing CD8+ T cell activation and proliferation
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MIF inhibition alleviates vitiligo progression by suppressing CD8+ T cell activation and proliferation
Authors
Keywords
-
Journal
JOURNAL OF PATHOLOGY
Volume 260, Issue 1, Pages 84-96
Publisher
Wiley
Online
2023-02-28
DOI
10.1002/path.6073
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sine oculis homeobox homolog 1 plays a critical role in pulmonary fibrosis
- (2022) Cory Wilson et al. JCI Insight
- Resident memory CD8+ T cells in regional lymph nodes mediate immunity to metastatic melanoma
- (2021) Aleksey K. Molodtsov et al. IMMUNITY
- Role of Cytokines in Vitiligo: Pathogenesis and Possible Targets for Old and New Treatments
- (2021) Paolo Custurone et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Anatomically distinct fibroblast subsets determine skin autoimmune patterns
- (2021) Zijian Xu et al. NATURE
- Vitiligo: Mechanisms of Pathogenesis and Treatment
- (2020) Michael L. Frisoli et al. Annual Review of Immunology
- Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer’s disease
- (2020) Elham Nasiri et al. MOLECULAR MEDICINE
- Macrophage inhibitory factor (MIF) gene polymorphisms are associated with disease susceptibility and with circulating MIF levels in active non‐segmental vitiligo in patients from western Mexico
- (2020) Alejandra Garcia‐Orozco et al. Molecular Genetics & Genomic Medicine
- CD49a Regulates Cutaneous Resident Memory CD8+ T Cell Persistence and Response
- (2020) Shannon K. Bromley et al. Cell Reports
- Mechanisms of melanocyte death in vitiligo
- (2020) Jianru Chen et al. MEDICINAL RESEARCH REVIEWS
- Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus
- (2019) Joshua B. Bilsborrow et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- NKG2D Defines a Subset of Skin Effector Memory CD8 T Cells with Proinflammatory Functions in Vitiligo
- (2019) Clément Jacquemin et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Macrophage migration inhibitory factor as an incriminating agent in vitiligo
- (2018) Azza Gaber Antar Farag et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences
- (2018) Paolo Fagone et al. JOURNAL OF NEUROIMMUNOLOGY
- Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: from pathogenic factors to therapeutic targets
- (2018) Sven Günther et al. DRUG DISCOVERY TODAY
- CD49a Expression Defines Tissue-Resident CD8 + T Cells Poised for Cytotoxic Function in Human Skin
- (2017) Stanley Cheuk et al. IMMUNITY
- Interferon-gamma Inhibits Melanogenesis and Induces Apoptosis in Melanocytes: A Pivotal Role of CD8+ Cytotoxic T Lymphocytes in Vitiligo
- (2015) L Yang et al. ACTA DERMATO-VENEREOLOGICA
- MIF: Implications in the Pathoetiology of Systemic Lupus Erythematosus
- (2015) Tali Lang et al. Frontiers in Immunology
- Vitiligo
- (2015) Mauro Picardo et al. Nature Reviews Disease Primers
- Autoimmune Vitiligo Does Not Require the Ongoing Priming of Naive CD8 T Cells for Disease Progression or Associated Protection against Melanoma
- (2014) K. T. Byrne et al. JOURNAL OF IMMUNOLOGY
- Mucosal Imprinting of Vaccine-Induced CD8+ T Cells Is Crucial to Inhibit the Growth of Mucosal Tumors
- (2013) F. Sandoval et al. Science Translational Medicine
- Relationship of macrophage migration inhibitory factor levels in PBMCs, lesional skin and serum with disease severity and activity in vitiligo vulgaris
- (2012) Lei Ma et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Inactivation of Tautomerase Activity of Macrophage Migration Inhibitory Factor by Sulforaphane: a Potential Biomarker for Anti-inflammatory Intervention
- (2011) Z. R. Healy et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma
- (2011) Katelyn T. Byrne et al. JOURNAL OF CLINICAL INVESTIGATION
- Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP kinase phosphorylation
- (2010) L. L. Santos et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Macrophage migration inhibitory factor in patients with vitiligo and relationship between duration and clinical type of disease
- (2009) G. Serarslan et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- MIF in autoimmunity and novel therapeutic approaches
- (2008) Stanislava Stosic-Grujicic et al. AUTOIMMUNITY REVIEWS
- Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus
- (2007) Stanislava Stosic-Grujicic et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Lymph node mapping in the mouse
- (2007) Maria I. Harrell et al. JOURNAL OF IMMUNOLOGICAL METHODS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started